Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans
- 1 November 1993
- journal article
- Published by Springer Nature in Diabetologia
- Vol. 36 (11) , 1191-1197
- https://doi.org/10.1007/bf00401065
Abstract
It is controversial as to whether ketone bodies are utilized by the human brain as a fuel alternative to glucose during hypoglycaemia. To clarify the issue, we studied 10 normal volunteers during an experimental hypoglycaemia closely mimicking the clinical hypoglycaemia of patients with Type 1 (insulin-dependent) diabetes mellitus or insulinoma. Hypoglycaemia was induced by a continuous infusion of insulin (0.40 mU·kg−1·min−1 for 8 h, plasma insulin ≈180 pmol/l) which decreased the plasma glucose concentration to approximately 3.1 mmol/l during the last 3 h of the studies. Subjects were studied on two occasions, i. e. spontaneous, counterregulatory-induced post-hypoglycaemic increase in 3-β-hydroxybutyrate (from ≈ 0.2 to ≈ 1.1 mmol/l at 8 h), or prevention of post-hypoglycaemic hyperketonaemia (plasma β-hydroxybutyrate ≈ 0.1 mmol/l throughout the study) after administration of acipimox, a potent inhibitor of lipolysis. In the latter study, glucose was infused to match the hypoglycaemia observed in the former study. The glycaemic thresholds and overall responses of counterregulatory hormones, symptoms (both autonomic and neuroglycopenic), and deterioration of cognitive function (psychomotor tests) were superimposable in the control study in which ketones increased spontaneously after onset of hypoglycaemic counterregulation, as compared to the study in which ketones were suppressed (p=NS). The fact that responses of counterregulatory hormones, symptoms and deterioration in cognitive function were not exaggerated when posthypoglycaemic hyperketonaemia was prevented, indicate that during hypoglycaemia, the counterregulatory-induced endogenous hyperketonaemia does not provide the human brain with an alternative substrate to glucose. Thus, it is concluded that during hypoglycaemia, endogenous hyperketonaemia does not contribute to brain metabolism and function.Keywords
This publication has 31 references indexed in Scilit:
- Incidence of Nocturnal Hypoglycaemia in Insulin-dependent Diabetic Patients on Intensive TherapyActa Medica Scandinavica, 2009
- Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.Journal of Clinical Investigation, 1992
- Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.Journal of Clinical Investigation, 1988
- Plasma Glucose Concentrations at the Onset of Hypoglycemic Symptoms in Patients with Poorly Controlled Diabetes and in NondiabeticsNew England Journal of Medicine, 1988
- Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.Journal of Clinical Investigation, 1987
- Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humansDiabetes, 1986
- Glucose Counterregulation, Hypoglycemia, and Intensive Insulin Therapy in Diabetes MellitusNew England Journal of Medicine, 1985
- Glucose Counterregulation and Waning of Insulin in the Somogyi Phenomenon (Posthypoglycemic Hyperglycemia)New England Journal of Medicine, 1984
- Abnormal Glucose Counterregulation after Subcutaneous Insulin in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1984
- Effects of free fatty acid availability, glucagon excess, and insulin deficiency on ketone body production in postabsorptive man.Journal of Clinical Investigation, 1983